Third Rock Ventures GP V, 10% Owner of Rapport Therapeutics RAPP, has filed 6 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $34.4M. The latest trade was on 05/26.

TV

TV

Third Rock Ventures GP V

10% Owner

Company

Rapport Therapeutics RAPP

First filing

23/11/14

Trades

30 trades

Buys / sales

6 / 5

12-month net buying

−$34.4M

Last trade

05/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Rapport TherapeuticsRAPP	Open-market sale10b5-1 plan	05/26	05/28	18,572 sh	$40.05	$743,808.6	−0.3%
Rapport TherapeuticsRAPP	Open-market sale10b5-1 plan	05/11	05/13	133,618 sh	$40.24	$5,376,788.32	−2.1%
Rapport TherapeuticsRAPP	Open-market sale10b5-1 plan	05/07–05/08	05/11	276,513 sh2 trades	$40.12avg.	$11,094,654.98	−4.1%
Rapport TherapeuticsRAPP	Open-market sale10b5-1 plan	04/17	04/21	426,005 sh	$40.32	$17,176,521.6	−6.0%
SepternaSEPN	Open-market buy	25/02/24	25/02/26	18,861 sh	$6.00	$113,166	+0.4%
SepternaSEPN	Open-market buy	25/02/20–25/02/21	25/02/24	1,040,342 sh2 trades	$5.93avg.	$6,167,378	+33.0%
SepternaSEPN	Open-market buy	24/10/28	24/10/28	650,000 sh2 trades	$18.00avg.	$11,700,000	No record
CT Cargo Therapeutics	Open-market buy	23/11/14	23/11/14	1,333,333 sh	$15.00	$19,999,995	+281.4%